DE60234469D1 - Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung - Google Patents

Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung

Info

Publication number
DE60234469D1
DE60234469D1 DE60234469T DE60234469T DE60234469D1 DE 60234469 D1 DE60234469 D1 DE 60234469D1 DE 60234469 T DE60234469 T DE 60234469T DE 60234469 T DE60234469 T DE 60234469T DE 60234469 D1 DE60234469 D1 DE 60234469D1
Authority
DE
Germany
Prior art keywords
hemostatic
agent
preparation
garnish
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234469T
Other languages
English (en)
Inventor
Joergen Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26069117&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60234469(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Application granted granted Critical
Publication of DE60234469D1 publication Critical patent/DE60234469D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/102—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60234469T 2001-12-21 2002-12-20 Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung Expired - Lifetime DE60234469D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101941 2001-12-21
EP02388028 2002-03-27
PCT/DK2002/000898 WO2003055531A2 (en) 2001-12-21 2002-12-20 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis

Publications (1)

Publication Number Publication Date
DE60234469D1 true DE60234469D1 (de) 2009-12-31

Family

ID=26069117

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234469T Expired - Lifetime DE60234469D1 (de) 2001-12-21 2002-12-20 Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung

Country Status (13)

Country Link
EP (3) EP1458425B1 (de)
JP (1) JP4527981B2 (de)
KR (1) KR101036696B1 (de)
CN (1) CN1290586C (de)
AT (1) ATE448808T1 (de)
AU (1) AU2002367086B2 (de)
CA (1) CA2470684A1 (de)
DE (1) DE60234469D1 (de)
HR (1) HRP20040670A2 (de)
HU (1) HUP0402322A3 (de)
NO (1) NO20042551L (de)
PL (1) PL371200A1 (de)
WO (1) WO2003055531A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US8440225B2 (en) 2003-08-07 2013-05-14 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20060019868A1 (en) 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
AR054636A1 (es) 2004-01-30 2007-07-11 Ferrosan As Dispositivo hemostatico
US7109163B2 (en) 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
JP2007519450A (ja) * 2004-01-30 2007-07-19 フェロサン アー／エス 止血用のスプレーおよび組成物
US8119160B2 (en) 2004-06-29 2012-02-21 Ethicon, Inc. Hemostatic compositions and devices
FR2881651A1 (fr) * 2005-02-09 2006-08-11 Urodelia Sa Nouveau produit pharmaceutique et procede de fabrication de ce produit pharmaceutique
RU2440810C2 (ru) * 2005-04-28 2012-01-27 Ново Нордиск Хелс Кеа Аг Закрытый контейнер, содержащий активированный полипептид фактора vii, способы его получения и набор и способ применения набора
JP2009136593A (ja) * 2007-12-10 2009-06-25 Nipro Corp 再生医療用器具の包装体
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
AU2011260258B2 (en) 2010-06-01 2015-07-09 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
MD4163C1 (ro) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos sub formă de gel pentru profilaxia complicaţiilor postoperatorii
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2825216B1 (de) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Trockene blutstillende zusammensetzung
CN105358071B (zh) 2013-06-21 2018-07-31 弗罗桑医疗设备公司 真空膨胀的干组合物和用于保留该干组合物的注射器
CN105828844B (zh) 2013-12-11 2019-09-27 弗罗桑医疗设备公司 包含挤出增强剂的干组合物
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
AU2015371184B2 (en) 2014-12-24 2020-06-25 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
AU2017310470B2 (en) * 2016-08-12 2021-12-16 Dilon Technologies Inc. Hemostatic flowable
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US11007299B2 (en) * 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
CN114470302A (zh) * 2022-01-19 2022-05-13 株洲茂物医疗科技有限公司 一种止血凝胶及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4522302A (en) * 1984-03-05 1985-06-11 Sterling Drug Inc. Pre-sterilized medical procedure kit packages
JPS6221357A (ja) 1985-07-22 1987-01-29 Toshiba Corp メモリシステム
JPS62221357A (ja) 1986-03-20 1987-09-29 ジエクス株式会社 生物体表面への塗布剤
JPS6485653A (en) * 1987-09-28 1989-03-30 Terumo Corp Drug receiving container
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
FR2679772B1 (fr) 1991-08-02 1995-05-19 Peters Sa Emboles en particules non resorbables enrobees de materiau hemostatique.
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5394886A (en) 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
CA2175203A1 (en) 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
ATE168554T1 (de) * 1994-05-23 1998-08-15 Liposome Co Inc Vorrichtung zur herstellung einer formulierung
US5588745A (en) * 1994-09-02 1996-12-31 Howmedica Methods and apparatus for mixing bone cement components using an evacuated mixing chamber
DE19513666C1 (de) * 1995-04-11 1996-11-28 Behringwerke Ag Vorrichtung zum Zusammenführen einer ersten flüssigen und einer zweiten festen oder flüssigen Komponente mittels Unterdruck unter sterilen Bedingungen
US6045570A (en) 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
FR2759980A1 (fr) * 1997-02-25 1998-08-28 Bras Michel Conditionnement de deux substances destinees a etre melangees
EP0993311B1 (de) 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Thrombin und mikrofibrillares collagen enthaltene zusammensetzung sowie herstellungsmethoden und dessen gebrauch
AUPP223498A0 (en) * 1998-03-06 1998-04-02 Southcorp Australia Pty Ltd A container
AU1086601A (en) 1999-10-15 2001-04-30 Genetics Institute Inc. Formulations for delivery of osteogenic proteins

Also Published As

Publication number Publication date
HUP0402322A3 (en) 2012-05-29
CA2470684A1 (en) 2003-07-10
EP1458425B1 (de) 2009-11-18
KR101036696B1 (ko) 2011-05-24
ATE448808T1 (de) 2009-12-15
AU2002367086B2 (en) 2008-08-21
CN1290586C (zh) 2006-12-20
EP2289566A1 (de) 2011-03-02
AU2002367086A1 (en) 2003-07-15
PL371200A1 (en) 2005-06-13
EP1458425A2 (de) 2004-09-22
KR20040093673A (ko) 2004-11-06
CN1615160A (zh) 2005-05-11
HUP0402322A2 (hu) 2005-03-29
WO2003055531A2 (en) 2003-07-10
NO20042551L (no) 2004-08-20
JP4527981B2 (ja) 2010-08-18
WO2003055531A3 (en) 2003-11-20
WO2003055531A8 (en) 2004-01-08
JP2005512734A (ja) 2005-05-12
HRP20040670A2 (en) 2005-06-30
EP2078532A1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
DE60234469D1 (de) Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung
Eldeniz et al. Shear bond strength of three resin based sealers to dentin with and without the smear layer
DE502004004911D1 (de) Medizinisches instrument zum schneiden von biologischem und insbesondere menschlichem gewebe
ATE478601T1 (de) Vorrichtung und verfahren zum positionieren eines elektrokardiogrammfühlers
ATE238815T1 (de) System und verfahren zur echtzeitüberwachung und kontrolle von behandlungssterilisation und parametrische freigabe
DE60028573D1 (de) Behandlung und zusammensetzungen zur erzielung eines hautalterungsschutzes durch corneum protease aktivatoren
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
DE69519912D1 (de) Injizierbare flüssige Copolymer zur Ausbesserung und Vermehrung von Weichteilgewebe
DE59913260D1 (de) Lichtapplikationseinrichtung zur photodynamischen diagnose und/oder photodynamischen therapie von erkrankungen des zahnhalteapparates und der zähne
PL1730299T3 (pl) Zestaw do pomiaru generacji trombiny w próbce krwi lub osocza pacjenta
WO2003010742A3 (en) Periodontal regeneration composition and method of using same
HK1055563A1 (en) Composition and method for the repair and regeneration of cartilage and other tissues
BR0103256A (pt) Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano
ATE231511T1 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
SE0402230D0 (sv) Container for a component
WO2008005996A3 (en) Medical/surgical lavage system capable of selectively and sequentially discharging either a base solution or a solution which includes a therapeutic agent
AU2003260330A1 (en) Apparatus for sealing punctures in blood vessels
DE59813579D1 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
BR0114254A (pt) Sistema ortopédico, método para modificação e de avanço de separação entre o maxilar e o zigoma de um paciente
NZ332947A (en) Topical niacin composition and its use in a diagnostic test for schizophrenia
ATE429940T1 (de) Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen
DE60320793D1 (de) Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe
Khoroushi et al. The effect of trichloracetic acid as a hemostatic and etching agent on the morphological characteristics and shear bond strength of resin composite to enamel
DE69419666T2 (de) Vorrichtung zum Verhindern der Schaumbildung bei den extrakorporalen Blutbehandlung und Verfahren zur Herstellung der Vorrichtung
ATE452906T1 (de) Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican

Legal Events

Date Code Title Description
8363 Opposition against the patent